In the first week of December, Ovohorse was awarded in the “Genetics” category thanks to the outstanding work and research of Ovoclone: animal cloning. The award was granted by the Institute for Professional and Business Excellence.
The gala, known as The European Awards, brought together the winners at the prestigious Ritz Hotel in Paris to present the awards for professional excellence and business innovation.
Ovoclone was born from the expertise of the professionals at the OVO Group; a team of more than 150 specialists, including embryologists, doctors, veterinarians, and researchers. Today, it is one of the best groups in reproductive medicine and cellular cryopreservation.
The scientific team of Ovoclone and Ovohorse successfully implemented animal cloning in Spain. This technique allows the cloning of a genetically healthy animal identical to an existing one. To carry out cloning, a biopsy is required to obtain the cells needed to start the replication process. Once the sample is obtained, the Ovoclone professionals handle the entire process, cultivating and developing the cells to create an embryo identical to the original animal (dog, cat, horse, or camel). Thanks to their expertise in cellular cryopreservation, the Ovohorse and Ovoclone teams also offer a genetic bank to store samples for future use.
Ovoclone represents the perfect combination of high-quality technology, highly qualified professionals, and years of experience in assisted reproduction.
The innovative project is led by embryologist and OVO Group CEO Enrique Criado Scholz. His professional career has been marked by numerous achievements in the field of human assisted reproduction. He has worked as an embryologist in top clinics in Italy and the United States, mastering advanced laboratory techniques and conducting research to improve cell freezing protocols. “We are constantly innovating, developing new procedures, and improving laboratory protocols to optimize genetic preservation and animal cloning results,” states Enrique Criado Scholz, CEO of Ovohorse and Ovoclone.
The Ovohorse project is made possible through the collaboration and expertise of Enrique Criado Scholz, embryologist, laboratory director, and CEO of the OVO Group, and Andrés Gambini, scientific director of Ovohorse, with over 12 years of experience in equine assisted reproduction.
